| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Activity of cabozantinib after immune checkpoint blockade in metastatic clear-cell renal cell carcinoma
|
McGregor, Bradley A.
|
|
|
135 |
C |
p. 203-210
|
artikel
|
| 2 |
Adaptation of multidisciplinary meeting decisions in a medical oncology department during the COVID epidemic in a less affected region of France: a prospective analysis from Bordeaux University Hospital
|
Heraudet, Luc
|
|
|
135 |
C |
p. 98-100
|
artikel
|
| 3 |
Adjuvant chemotherapy in small node-negative triple-negative breast cancer
|
Steenbruggen, Tessa G.
|
|
|
135 |
C |
p. 66-74
|
artikel
|
| 4 |
Ano-uro-genital mucosal melanoma UK national guidelines
|
Smith, Henry G.
|
|
|
135 |
C |
p. 22-30
|
artikel
|
| 5 |
A review of the international early recommendations for departments organization and cancer management priorities during the global COVID-19 pandemic: applicability in low- and middle-income countries
|
Belkacemi, Yazid
|
|
|
135 |
C |
p. 130-146
|
artikel
|
| 6 |
Cancer treatment during the coronavirus disease 2019 pandemic: Do not postpone but decide wisely
|
Huillard, Olivier
|
|
|
135 |
C |
p. 51
|
artikel
|
| 7 |
Chemoradiotherapy efficacy is predicted by intra-tumour CD8+/FoxP3+ double positive T cell density in locally advanced N2 non–small-cell lung carcinoma
|
Boulle, G.
|
|
|
135 |
C |
p. 221-229
|
artikel
|
| 8 |
Comment on ‘Effect of organised cervical cancer screening on cervical cancer mortality in Europe: a systematic review’
|
Dugué, Pierre-Antoine
|
|
|
135 |
C |
p. 240-241
|
artikel
|
| 9 |
Comment on “The experience on coronavirus disease 2019 and cancer from an oncology hub institution in Milan, Lombardy Region” and reflections from the Italian Association of Oncology Nurses
|
Biagioli, Valentina
|
|
|
135 |
C |
p. 8-10
|
artikel
|
| 10 |
Comparative analysis of docetaxel: physical and chemical characterisation of Taxotère® and generics
|
Pétronille, Roy
|
|
|
135 |
C |
p. 183-191
|
artikel
|
| 11 |
Conceptual framework for precision cancer medicine in Germany: Consensus statement of the Deutsche Krebshilfe working group ‘Molecular Diagnostics and Therapy’
|
Westphalen, C. Benedikt
|
|
|
135 |
C |
p. 1-7
|
artikel
|
| 12 |
Cost-effectiveness of lung cancer screening with low-dose computed tomography in heavy smokers: a microsimulation modelling study
|
Du, Yihui
|
|
|
135 |
C |
p. 121-129
|
artikel
|
| 13 |
Developing a risk assessment score for patients with cancer during the coronavirus disease 2019 pandemic
|
Indini, Alice
|
|
|
135 |
C |
p. 47-50
|
artikel
|
| 14 |
Health-related quality of life in patients with RAS wild-type metastatic colorectal cancer treated with panitumumab-based first-line treatment strategy: A pre-specified secondary analysis of the Valentino study
|
Raimondi, Alessandra
|
|
|
135 |
C |
p. 230-239
|
artikel
|
| 15 |
High mortality rate in cancer patients with symptoms of COVID-19 with or without detectable SARS-COV-2 on RT-PCR
|
Assaad, Souad
|
|
|
135 |
C |
p. 251-259
|
artikel
|
| 16 |
Hypothyroidism correlates with favourable survival prognosis in patients with brain metastatic cancer
|
Berghoff, Anna S.
|
|
|
135 |
C |
p. 150-158
|
artikel
|
| 17 |
Immune checkpoint inhibitors: a physiology-driven approach to the treatment of coronavirus disease 2019
|
Di Cosimo, Serena
|
|
|
135 |
C |
p. 62-65
|
artikel
|
| 18 |
Immune-related pneumonitis with nivolumab and ipilimumab during the coronavirus disease 2019 (COVID-19) pandemic
|
Souza, Ive L.
|
|
|
135 |
C |
p. 147-149
|
artikel
|
| 19 |
Less is more: A systematic review and meta-analysis of the outcomes of radical versus conservative primary resection in anorectal melanoma
|
Smith, Henry G.
|
|
|
135 |
C |
p. 113-120
|
artikel
|
| 20 |
Open-label, phase IIa study of dabrafenib plus trametinib in East Asian patients with advanced BRAF V600-mutant cutaneous melanoma
|
Si, Lu
|
|
|
135 |
C |
p. 31-38
|
artikel
|
| 21 |
Organisational challenges, volumes of oncological activity and patients' perception during the severe acute respiratory syndrome coronavirus 2 epidemic
|
Zuliani, Serena
|
|
|
135 |
C |
p. 159-169
|
artikel
|
| 22 |
Overall survival benefit of symptom monitoring in real-world patients with chronic lymphocytic leukaemia treated with ibrutinib: a FiLO group study
|
Ysebaert, Loic
|
|
|
135 |
C |
p. 170-172
|
artikel
|
| 23 |
Palliation of dysphagia in metastatic oesogastric cancers: An international multidisciplinary position
|
Levy, Antonin
|
|
|
135 |
C |
p. 103-112
|
artikel
|
| 24 |
Past and present of computer-assisted dermoscopic diagnosis: performance of a conventional image analyser versus a convolutional neural network in a prospective data set of 1,981 skin lesions
|
Sies, Katharina
|
|
|
135 |
C |
p. 39-46
|
artikel
|
| 25 |
Pathological complete response after neoadjuvant immunotherapy for a patient with microsatellite instability locally advanced rectal cancer: should we adapt our standard management for these patients?
|
Mans, L.
|
|
|
135 |
C |
p. 75-77
|
artikel
|
| 26 |
Phase II results from a phase I/II study to assess the safety and efficacy of weekly nab-paclitaxel in paediatric patients with recurrent or refractory solid tumours: A collaboration with the European Innovative Therapies for Children with Cancer Network
|
Amoroso, Loredana
|
|
|
135 |
C |
p. 89-97
|
artikel
|
| 27 |
Prognostic impact of immune-microenvironment in colorectal liver metastases resected after triplets plus a biologic agent: A pooled analysis of five prospective trials
|
Moretto, Roberto
|
|
|
135 |
C |
p. 78-88
|
artikel
|
| 28 |
Quantitative and qualitative impairments in dendritic cell subsets of patients with ovarian or prostate cancer
|
Mastelic-Gavillet, Beatris
|
|
|
135 |
C |
p. 173-182
|
artikel
|
| 29 |
Randomised phase II study of panitumumab plus irinotecan versus cetuximab plus irinotecan in patients with KRAS wild-type metastatic colorectal cancer refractory to fluoropyrimidine, irinotecan and oxaliplatin (WJOG 6510G)
|
Sakai, Daisuke
|
|
|
135 |
C |
p. 11-21
|
artikel
|
| 30 |
SARS-CoV-2 infection in cancer patients undergoing active treatment: analysis of clinical features and predictive factors for severe respiratory failure and death
|
Yarza, Ramón
|
|
|
135 |
C |
p. 242-250
|
artikel
|
| 31 |
Stability of nivolumab in its original vials after opening and handing in normal saline bag for intravenous infusion
|
Le Guyader, G.
|
|
|
135 |
C |
p. 192-202
|
artikel
|
| 32 |
Stereotactic radiosurgery combined with anti-PD1 for the management of melanoma brain metastases: A retrospective study of safety and efficacy
|
Carron, Romain
|
|
|
135 |
C |
p. 52-61
|
artikel
|
| 33 |
Survivorship in immune therapy: Assessing toxicities, body composition and health-related quality of life among long-term survivors treated with antibodies to programmed death-1 receptor and its ligand
|
Patrinely Jr., James Randall
|
|
|
135 |
C |
p. 211-220
|
artikel
|
| 34 |
Working in the dark: Interaction with a sub clinical COVID-19 subject and lessons learned
|
Rathod, Shrinivas
|
|
|
135 |
C |
p. 101-102
|
artikel
|
Tijdschrift beschrijving